Skip to main content

Advertisement

Log in

MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objective

The aim of this sub-analysis was to highlight the MASCC/ISOO clinical practice guidelines for the management of oral mucositis (OM) in pediatric patients and to present unique considerations in this patient population.

Methods

This sub-analysis of the pediatric patient population is based on the systematic review conducted by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISSO) published in 2019/2020. Studies were scored and assigned a level of evidence based on previously published criteria. Data regarding adverse effects and compliance was collected from the original publications.

Results

A total of 45 papers were included and assessed in this sub-analysis, including 21 randomized controlled trials (RCTs). Chewing gum was demonstrated to be not effective in preventing OM in pediatric cancer patients in 2 RCTs. The efficacy of all other interventions could not be determined based on the available literature.

Conclusion

There is limited or conflicting evidence about interventions for the management of OM in pediatric cancer patients, except for chewing gum which was ineffective for prevention. Therefore, currently, data from adult studies may need to be extrapolated for the management of pediatric patients. Honey and photobiomodulation therapy in this patient population had encouraging potential. Implementation of a basic oral care protocol is advised amid lack of high level of evidence studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FKL, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 19(8):2201–2205

    CAS  PubMed  Google Scholar 

  2. He M, Zhang B, Shen N, Wu N, Sun J (2018) A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr. 177(1):7–17

    PubMed  Google Scholar 

  3. Mazhari F, Shirazi AS, Shabzendehdar M (2019) Management of oral mucositis in pediatric patients receiving cancer therapy: A systematic review and meta-analysis. Pediatr Blood Cancer. 66(3):e27403

    PubMed  Google Scholar 

  4. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 62(6):400–422

    PubMed  Google Scholar 

  5. Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DA (1983) Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet. 2(8365-66):1452–1454

    CAS  PubMed  Google Scholar 

  6. Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 14(6):1201–1207

    CAS  PubMed  Google Scholar 

  7. Bezinelli LM, de Paula EF, da Graca Lopes RM, Biazevic MG, de Paula EC, Correa L et al (2014) Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol. 32(1):31–39

    PubMed  Google Scholar 

  8. Ariyawardana A, Cheng KKF, Kandwal A, Tilly V, Al-Azri AR, Galiti D et al (2019) Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 27(10):3985–3995

    PubMed  Google Scholar 

  9. Bowen JM, Gibson RJ, Coller JK, Blijlevens N, Bossi P, Al-Dasooqi N et al (2019) Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Support Care Cancer. 27(10):4011–4022

    PubMed  Google Scholar 

  10. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S (2020) Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 28(5):2449–2456

    PubMed  Google Scholar 

  11. Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D et al (2019) Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 27(10):3949–3967

    PubMed  Google Scholar 

  12. Logan RM, Al-Azri AR, Bossi P, Stringer AM, Joy JK, Soga Y et al (2020) Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 28(5):2485–2498

    PubMed  Google Scholar 

  13. Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J et al (2020) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 28(5):2473–2484

    PubMed  Google Scholar 

  14. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M et al (2020) Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents. Support Care Cancer. 28(5):2457–2472

    PubMed  Google Scholar 

  15. Yarom N, Hovan A, Bossi P, Ariyawardana A, Jensen SB, Gobbo M et al (2019) Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer. 27(10):3997–4010

    PubMed  Google Scholar 

  16. Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ et al (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 27(10):3969–3983

    PubMed  Google Scholar 

  17. Ranna V, Cheng KKF, Castillo DA, Porcello L, Vaddi A, Lalla RV et al (2019) Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods. Support Care Cancer. 27(10):3933–3948

    PubMed  Google Scholar 

  18. Somerfield MR, McCrae RR (2000) Stress and coping research. Methodological challenges, theoretical advances, and clinical applications. Am Psychol. 55(6):620–625

    CAS  PubMed  Google Scholar 

  19. Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol. 49(7):749–754

    CAS  PubMed  Google Scholar 

  20. Rojas de Morales T, Zambrano O, Rivera L, Navas R, Chaparro N, Bernardonni C et al (2001) Oral-disease prevention in children with cancer: testing preventive protocol effectiveness. Med Oral. 6(5):326–334

    CAS  PubMed  Google Scholar 

  21. Chen CF, Wang RH, Cheng SN, Chang YC (2004) Assessment of chemotherapy-induced oral complications in children with cancer. J Pediatr Oncol Nurs. 21(1):33–39

    PubMed  Google Scholar 

  22. Cheng KK, Molassiotis A, Chang AM (2002) An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study. Eur J Oncol Nurs. 6(2):66–73

    CAS  PubMed  Google Scholar 

  23. Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS (2001) Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer. 37(16):2056–2063

    CAS  PubMed  Google Scholar 

  24. Levy-Polack MP, Sebelli P, Polack NL (1998) Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care Dentist. 18(5):189–193

    CAS  PubMed  Google Scholar 

  25. Yavuz B, Bal YH (2015) Investigation of the effects of planned mouth care education on the degree of oral mucositis in pediatric oncology patients. J Pediatr Oncol Nurs. 32(1):47–56

    PubMed  Google Scholar 

  26. Cheng KK, Chang AM, Yuen MP (2004) Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. Eur J Cancer. 40(8):1208–1216

    CAS  PubMed  Google Scholar 

  27. Costa EM, Fernandes MZ, Quinder LB, de Souza LB, Pinto LP (2003) Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia. Pesqui Odontol Bras. 17(2):147–150

    PubMed  Google Scholar 

  28. Raether D, Walker PO, Bostrum B, Weisdorf D (1989) Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population. Pediatr Dent. 11(1):37–42

    CAS  PubMed  Google Scholar 

  29. Cheng KK (2004) Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis. Eur J Oncol Nurs. 8(4):341–349

    CAS  PubMed  Google Scholar 

  30. Cheng KK, Chang AM (2003) Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs. 26(6):476–484

    CAS  PubMed  Google Scholar 

  31. Lever SA, Dupuis LL, Chan HS (1987) Comparative evaluation of benzydamine oral rinse in children with antineoplastic-induced stomatitis. Drug Intell Clin Pharm. 21(4):359–361

    CAS  PubMed  Google Scholar 

  32. Shenep JL, Kalwinsky DK, Hutson PR, George SL, Dodge RK, Blankenship KR, Thornton D (1988) Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr. 113(4):758–763

    CAS  PubMed  Google Scholar 

  33. Bondi E, Baroni C, Prete A, Gatti M, Carrassi A, Lodi G, Porters SR (1997) Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. Oral Oncol. 33(5):322–326

    CAS  PubMed  Google Scholar 

  34. Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD et al (2013) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 21(11):3191–3207

    PubMed  Google Scholar 

  35. Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB (1996) Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr. 129(5):722–728

    CAS  PubMed  Google Scholar 

  36. Mackie AM, Coda BC, Hill HF (1991) Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain. 46(3):265–269

    PubMed  Google Scholar 

  37. James PJ, Howard RF, Williams DG (2010) The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain. Paediatr Anaesth. 20(9):805–811

    PubMed  Google Scholar 

  38. Lucchese A, Matarese G, Ghislanzoni LH, Gastaldi G, Manuelli M, Gherlone E (2016) Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia. Leuk Lymphoma. 57(4):820–827

    CAS  PubMed  Google Scholar 

  39. Lucchese A, Matarese G, Manuelli M, Ciuffreda C, Bassani L, Isola G, Cordasco G, Gherlone E (2016) Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial. Minerva Stomatol. 65(1):43–50

    PubMed  Google Scholar 

  40. Morris J, Rudebeck M, Neudorf S, Moore T, Duerst R, Shah AJ, Graham M, Aquino V, Morris C, Olsson B (2016) Safety, pharmacokinetics, and efficacy of palifermin in children and adolescents with acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium trial. Biol Blood Marrow Transplant. 22(7):1247–1256

    CAS  PubMed  Google Scholar 

  41. Czyzewski K, Debski R, Krenska A, Wysocki M, Styczynski J (2014) Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis. Anticancer Res. 34(12):7379–7382

    CAS  PubMed  Google Scholar 

  42. Lauritano D, Petruzzi M, Di Stasio D, Lucchese A (2014) Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci. 6(1):27–30

    CAS  PubMed  Google Scholar 

  43. Vitale KM, Violago L, Cofnas P, Bishop J, Jin Z, Bhatia M, Kung AL, George D, Garvin J, Satwani P (2014) Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases. Pediatr Transplant. 18(2):211–216

    CAS  PubMed  Google Scholar 

  44. Patte C, Laplanche A, Bertozzi AI, Baruchel A, Frappaz D, Schmitt C, Mechinaud F, Nelken B, Boutard P, Michon J (2002) Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. J Clin Oncol. 20(2):441–448

    CAS  PubMed  Google Scholar 

  45. Gordon B, Spadinger A, Hodges E, Ruby E, Stanley R, Coccia P (1994) Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol. 12(9):1917–1922

    CAS  PubMed  Google Scholar 

  46. de Koning BA, Philipsen-Geerling B, Hoijer M, Hahlen K, Buller HA, Pieters R (2007) Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study. Pediatr Blood Cancer. 48(5):532–539

    PubMed  Google Scholar 

  47. Raphael MF, den Boer AM, Kollen WJ, Mekelenkamp H, Abbink FC, Kaspers GJ et al (2014) Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children? : Results from a prospective multicenter double blind randomized controlled trial. Support Care Cancer. 22(1):3–6

    CAS  PubMed  Google Scholar 

  48. Uderzo C, Rebora P, Marrocco E, Varotto S, Cichello F, Bonetti M, Maximova N, Zanon D, Fagioli F, Nesi F, Masetti R, Rovelli A, Rondelli R, Valsecchi MG, Cesaro S (2011) Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study. Transplantation. 91(12):1321–1325

    CAS  PubMed  Google Scholar 

  49. Kuskonmaz B, Yalcin S, Kucukbayrak O, Cetin N, Cetin M, Tezcan I, Uckan D (2008) The effect of glutamine supplementation on hematopoietic stem cell transplant outcome in children: a case-control study. Pediatr Transplant. 12(1):47–51

    CAS  PubMed  Google Scholar 

  50. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH et al (2005) A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant. 36(7):611–616

    CAS  PubMed  Google Scholar 

  51. Ward E, Smith M, Henderson M, Reid U, Lewis I, Kinsey S, Allgar V, Bowers D, Picton SV (2009) The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. Eur J Clin Nutr. 63(1):134–140

    CAS  PubMed  Google Scholar 

  52. Yildirim ZK, Bidev D, Buyukavci M (2013) Parenteral glutamine supplementation has no effect on chemotherapy-induced toxicity in children with non-Hodgkin lymphoma. J Pediatr Hematol Oncol. 35(5):371–376

    CAS  PubMed  Google Scholar 

  53. Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, Feldman BM (2007) Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer. 43(8):1269–1275

    CAS  PubMed  Google Scholar 

  54. Khurana H, Pandey RK, Saksena AK, Kumar A (2013) An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy. Oral Dis. 19(5):456–464

    CAS  PubMed  Google Scholar 

  55. Hamidieh AA, Sherafatmand M, Mansouri A, Hadjibabaie M, Ashouri A, Jahangard-Rafsanjani Z, Gholami K, Javadi MR, Ghavamzadeh A, Radfar M (2016) Calcitriol for oral mucositis prevention in patients with Fanconi anemia undergoing hematopoietic SCT: a double-blind, randomized, placebo-controlled trial. Am J Ther. 23(6):e1700–e17e8

    PubMed  Google Scholar 

  56. Abdulrhman M, Elbarbary NS, Ahmed Amin D, Saeid ER (2012) Honey and a mixture of honey, beeswax, and olive oil-propolis extract in treatment of chemotherapy-induced oral mucositis: a randomized controlled pilot study. Pediatr Hematol Oncol. 29(3):285–292

    PubMed  Google Scholar 

  57. Tomaževič T, Jazbec J (2013) A double blind randomised placebo controlled study of propolis (bee glue) effectiveness in the treatment of severe oral mucositis in chemotherapy treated children. Complement Ther Med. 21(4):306–312

    PubMed  Google Scholar 

  58. Oberbaum M, Yaniv I, Ben-Gal Y, Stein J, Ben-Zvi N, Freedman LS, Branski D (2001) A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer. 92(3):684–690

    CAS  PubMed  Google Scholar 

  59. Sencer SF, Zhou T, Freedman LS, Ives JA, Chen Z, Wall D, Nieder ML, Grupp SA, Yu LC, Sahdev I, Jonas WB, Wallace JD, Oberbaum M (2012) Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplant. 47(11):1409–1414

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Eghbali A, Taherkhanchi B, Bagheri B, Sadeghi SB (2016) Effect of chewing gum on oral mucositis in children undergoing chemotherapy: a randomized controlled study. Iran J Ped Hematol Oncol. 6(1):9–14

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Gandemer V, Le Deley MC, Dollfus C, Auvrignon A, Bonnaure-Mallet M, Duval M et al (2007) Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol. 29(2):86–94

    PubMed  Google Scholar 

  62. Sato A, Saisho-Hattori T, Koizumi Y, Minegishi M, Iinuma K, Imaizumi M (2006) Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy. Tohoku J Exp Med. 210(4):315–320

    CAS  PubMed  Google Scholar 

  63. Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, Majorana A (2016) Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci. 31(6):1231–1236

    PubMed  Google Scholar 

  64. Chermetz M, Gobbo M, Ronfani L, Ottaviani G, Zanazzo GA, Verzegnassi F, Treister NS, di Lenarda R, Biasotto M, Zacchigna S (2014) Class IV laser therapy as treatment for chemotherapy-induced oral mucositis in onco-haematological paediatric patients: a prospective study. Int J Paediatr Dent. 24(6):441–449

    PubMed  Google Scholar 

  65. Whelan HT, Connelly JF, Hodgson BD, Barbeau L, Post AC, Bullard G, Buchmann EV, Kane M, Whelan NT, Warwick A, Margolis D (2002) NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg. 20(6):319–324

    PubMed  Google Scholar 

  66. Pytlík R, Benes P, Patorková M, Chocenská E, Gregora E, Procházka B, Kozák T (2002) Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant. 30(12):953–961

    PubMed  Google Scholar 

  67. Tomlinson D, Gibson F, Treister N, Baggott C, Judd P, Hendershot E, Maloney AM, Doyle J, Feldman B, Kwong K, Sung L (2009) Understandability, content validity, and overall acceptability of the Children's International Mucositis Evaluation Scale (ChIMES): child and parent reporting. J Pediatr Hematol Oncol. 31(6):416–423

    PubMed  Google Scholar 

  68. Noirrit-Esclassan E, Valera MC, Vignes E, Munzer C, Bonal S, Daries M, Vaysse F, Puiseux C, Castex MP, Boulanger C, Pasquet M (2019) Photobiomodulation with a combination of two wavelengths in the treatment of oral mucositis in children: The PEDIALASE feasibility study. Arch Pediatr. 26(5):268–274

    CAS  PubMed  Google Scholar 

  69. Treister NS, London WB, Guo D, Malsch M, Verrill K, Brewer J, Margossian S, Duncan C (2016) A feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed Laser Surg. 34(4):178–184

    PubMed  Google Scholar 

  70. Ljungman L, Cernvall M, Ghaderi A, Ljungman G, von Essen L, Ljótsson B (2018) An open trial of individualized face-to-face cognitive behavior therapy for psychological distress in parents of children after end of treatment for childhood cancer including a cognitive behavioral conceptualization. PeerJ. 6:e4570

    PubMed  PubMed Central  Google Scholar 

  71. Barros IM, Alcântara TS, Mesquita AR, Santos AC, Paixão FP, Lyra DP Jr (2014) The use of pictograms in the health care: a literature review. Res Social Adm Pharm. 10(5):704–719

    PubMed  Google Scholar 

  72. Li WH, Chung JO, Ho EK (2011) The effectiveness of therapeutic play, using virtual reality computer games, in promoting the psychological well-being of children hospitalised with cancer. J Clin Nurs. 20(15-16):2135–2143

    PubMed  Google Scholar 

  73. Lopes-Junior LC, Silveira DSC, Olson K, Bomfim EO, Veronez LC, Santos JC et al (2019) Clown intervention on psychological stress and fatigue in pediatric patients with cancer undergoing chemotherapy. Cancer Nurs

  74. Silva NB, Osório FL (2018) Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients. PLoS One. 13(4):e0194731

    PubMed  PubMed Central  Google Scholar 

  75. Lopez-Rodriguez MM, Fernández-Millan A, Ruiz-Fernández MD, Dobarrio-Sanz I, Fernández-Medina IM (2020) New technologies to improve pain, anxiety and depression in children and adolescents with cancer: a systematic review. Int J Environ Res Public Health 17(10)

  76. Konuk Sener D, Aydin M, Cangur S, Guven E (2019) The effect of oral care with Chlorhexidine, vitamin E and honey on mucositis in pediatric intensive care patients: a randomized controlled trial. J Pediatr Nurs. 45:e95–e101

    PubMed  Google Scholar 

  77. Alkhouli M, Laflouf M, Alhaddad M (2020) Efficacy of aloe-vera use for prevention of chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia: a randomized controlled clinical trial. Compr Child Adolesc Nurs.:1–14

  78. Al Jaouni SK, Al Muhayawi MS, Hussein A, Elfiki I, Al-Raddadi R, Al Muhayawi SM et al (2017) Effects of Honey on oral mucositis among pediatric cancer patients undergoing chemo/radiotherapy treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Evid Based Complement Alternat Med 2017:5861024

    PubMed  PubMed Central  Google Scholar 

  79. Eslami H, Pouralibaba F, Falsafi P, Bohluli S, Najati B, Negahdari R, Ghanizadeh M (2016) Efficacy of Hypozalix spray and propolis mouthwash for prevention of chemotherapy-induced oral mucositis in leukemic patients: A double-blind randomized clinical trial. J Dent Res Dent Clin Dent Prospects. 10(4):226–233

    PubMed  PubMed Central  Google Scholar 

  80. Tavakoli Ardakani M, Ghassemi S, Mehdizadeh M, Mojab F, Salamzadeh J, Ghassemi S, Hajifathali A (2016) Evaluating the effect of Matricaria recutita and Mentha piperita herbal mouthwash on management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: A randomized, double blind, placebo controlled clinical trial. Complement Ther Med. 29:29–34

    PubMed  Google Scholar 

  81. Treister N, Nieder M, Baggott C, Olson E, Chen L, Dang H, Krailo M, August A, Sung L (2017) Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation. Br J Cancer. 116(1):21–27

    CAS  PubMed  Google Scholar 

  82. Bardellini E, Amadori F, Schumacher RF, D'Ippolito C, Porta F, Majorana A (2016) Efficacy of a solution composed by verbascoside, polyvinylpyrrolidone (PVP) and sodium hyaluronate in the treatment of chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 38(7):559–562

    CAS  PubMed  Google Scholar 

  83. Gobbo M, Verzegnassi F, Ronfani L, Zanon D, Melchionda F, Bagattoni S, Majorana A, Bardellini E, Mura R, Piras A, Petris MG, Mariuzzi ML, Barone A, Merigo E, Decembrino N, Vitale MC, Berger M, Defabianis P, Biasotto M, Ottaviani G, Zanazzo GA (2018) Multicenter randomized, double-blind controlled trial to evaluate the efficacy of laser therapy for the treatment of severe oral mucositis induced by chemotherapy in children: laMPO RCT. Pediatr Blood Cancer. 65(8):e27098

    PubMed  Google Scholar 

  84. Medeiros-Filho JB, Maia Filho EM, Ferreira MC (2017) Laser and photochemotherapy for the treatment of oral mucositis in young patients: Randomized clinical trial. Photodiagnosis Photodyn Ther. 18:39–45

    PubMed  Google Scholar 

  85. Ribeiro da Silva VC, da Motta Silveira FM, Barbosa Monteiro MG, da Cruz MMD, Caldas Junior AF, Pina Godoy G. Photodynamic therapy for treatment of oral mucositis: Pilot study with pediatric patients undergoing chemotherapy. Photodiagnosis Photodyn Ther. 2018;21:115-20.

  86. Vitale MC, Modaffari C, Decembrino N, Zhou FX, Zecca M, Defabianis P (2017) Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT). Lasers Med Sci. 32(6):1423–1428

    PubMed  Google Scholar 

  87. Kamsvåg T, Svanberg A, Legert KG, Arvidson J, von Essen L, Mellgren K et al (2020) Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial. Support Care Cancer

  88. Tsurusawa M, Watanabe T, Gosho M, Mori T, Mitsui T, Sunami S, Kobayashi R, Fukano R, Tanaka F, Fujita N, Inada H, Sekimizu M, Koh K, Kosaka Y, Komada Y, Saito AM, Nakazawa A, Horibe K, for the lymphoma committee of the Japanese Pediatric Leukemia/lymphoma Study Group (2016) Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study group B-NHL03 study. Leuk Lymphoma 57(7):1657–1664

    CAS  PubMed  Google Scholar 

  89. Gholizadeh N, Mehdipoor M, Sajadi H, Moosavi MS (2016) Palifermin and chlorhexidine mouthwashes in prevention of chemotherapy-induced mucositis in children with acute lymphocytic leukemia: a randomized controlled trial. J Dent (Shiraz). 17(4):343–347

    PubMed Central  Google Scholar 

  90. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. https://doi.org/10.1002/cncr.33100

Download references

Acknowledgments

The authors would like to thank the members of the Mucositis Study Group of MASC/ISOO who contributed to the guidelines development. The authors thank Rachel Lubart, PhD, and Lilach Gavish, PhD, for advising on laser physics.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Wanessa Miranda-Silva.

Ethics declarations

Conflict of interest

PRA has received grants and personal fees from PhotomedTech, personal fees from Kerber Applied Research, personal fees from Seaborough, personal fees from Shepherd University, non-financial support from National Institute of Aging, NIH, personal fees from Curalaser, personal fees and non-financial support from Vielight, personal fees from Zoovv, non-financial support from Thor Photomedicine, non-financial support from Weber Medical, non-financial support from K laser (Summa), non-financial support from Biolase, non-financial support from Irradia, non-financial support from Quasar Biotech, and non-financial support from Light scalpel, outside the submitted work; In addition, PRA has a patent light-based dental systems issued.

PB has served an advisory role for Merck Serono, Sanofi, Merck Sharp & Dohme, Sun Pharma, Angelini, Astra Zeneca, Bristol-Myers-Squibb, Helsinn, and GSK and received grants from Merck, Kyowa Hakko Kirin, and Roche. WMS, WGS, YZ, NY, ARAA, CHLH, AA, DPS, MEC, JB, KKFC, WJET, and SE declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miranda-Silva, W., Gomes-Silva, W., Zadik, Y. et al. MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Support Care Cancer 29, 3539–3562 (2021). https://doi.org/10.1007/s00520-020-05803-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-020-05803-4

Keywords

Navigation